nrr podcast logo

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View full description +

LATEST EPISODE

10.29.26

AAO '26: BRUNELLO and LUGANO

Donald J. D'Amico, MD; and Carl Regillo, MD

Could a Wnt pathway agonist match anti-VEGF therapy for DME, and what should we make of a phase 3 trial that hit its anatomic goals but missed its primary visual endpoint? Don D’Amico, MD, reviews one-year results from the phase 2b/3 BRUNELLO study of remigromig (Restoret, Merck/EyeBio), a Wnt pathway agonist, for diabetic macular edema. And Carl Regillo, MD, discusses the phase 3 LUGANO study of EYP-1901 (vorolanib, EyePoint Pharmaceuticals) for wet AMD, which missed its primary endpoint despite reducing treatment burden by 42%.

Play Episode

MORE EPISODES

10.22.26

AAO '26: Fluid Debates in Wet AMD + OTX-TKI for Wet AMD

Avni Finn, MD; and Darius Moshfeghi, MD

10.15.26

PPV vs Phacovitrectomy for RRD in Phakic Eyes

Vaidehi Dedania, MD; Yewlin Chee, MD; and Joshua Uhr, MD

10.01.26

The Fellow Eye: Episode 7

Justin C. Muste, MD; David Fell, MD; Matthew Starr, MD; and Timothy Xu, MD

09.24.26

Spotlight on UNITY® VCS: 50 Cases In

Matthew Cunningham, MD, FASRS and Steven Yeh, MD, FASRS

09.18.26

Vitreous Hemorrhage Following PVD: Who Needs Surgery?

Barton Blackorby, MD, Matt Starr, MD, and Kyle Kovacs, MD

09.10.26

Spotlight on UNITY® VCS: Breaking New Ground

Jay Sridhar, MD; and Nina Berrocal, MD

08.27.26

ASRS '26: ArMaDa/GARDian Results and Real-World YAG Complication Incidence

Jay Chhablani, MD; and Jordan Deaner, MD

08.20.26

Comparing Ocular AEs in Next-Gen Treatments

Katherine Talcott, MD; Akshay Thomas, MD; and Nita Valikodath, MD, MS

Show More